3Joensuu H,Eriksson M, Hall KS, et al. One vs Three years ot adjuvant imatinib for operable gastrointestinal strornal tumor: a randomized trial[ J]. JAMA,2012,307( 12 ) : 1265-1272.
3Miettinen M, Lasota J. Gastrointestinal stromal lumors: definition, clinical, histological, imrm'nohistochemieal, and molecular genetic featues and differentinal diagnosis. Arch Pathol Lab Med ,2006,130 : 1466-1478.
4Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol, 2008, 39: 1411-1419.
5师英强,梁小波,等.胃肠道间质瘤.北京:人民卫生出版社,2011,3:62-67.
6Park SS, Ryu JS, Oh SY, et al. Surgical outcomes and immunohistoehemieal fealures for gastrointestinal stromal tumors (GISTS) of the stromach: with special refer'erue to prognostic fastms, Hepatogastmenterology ,2007, 54 : 1454-1457.
7Miettinen M,Lasota J. Gastrointestinal stromal tumors:review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med,2006,130:1466-1478.
8Tien YW, Lee CY, Huang CC, et al. Surgical for gastrointestinal stromal tumors of the duodenum. Ann Surg Oncol, 2010, 17: 109-114.
9Caterino S, Lorenzou L, Petrueeiani N, et al. Gastrointestinal stromal tumors: correlations between syoptoms at presentation, tumor location and prognostic factors in 47 consecutive patients. WoAd J Surg Oneol,2011,9 : 13-23.
